COLOMBO, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 14.767
AS - Asia 12.768
EU - Europa 8.141
SA - Sud America 1.735
AF - Africa 521
Continente sconosciuto - Info sul continente non disponibili 238
OC - Oceania 28
Totale 38.198
Nazione #
US - Stati Uniti d'America 14.301
SG - Singapore 4.499
CN - Cina 4.021
VN - Vietnam 1.783
IE - Irlanda 1.443
FI - Finlandia 1.384
BR - Brasile 1.316
SE - Svezia 1.251
HK - Hong Kong 860
UA - Ucraina 834
DE - Germania 812
IT - Italia 812
TR - Turchia 499
FR - Francia 413
ZA - Sudafrica 390
NL - Olanda 372
GB - Regno Unito 316
CA - Canada 271
BD - Bangladesh 261
IN - India 168
RU - Federazione Russa 150
AR - Argentina 146
KR - Corea 117
MX - Messico 85
CO - Colombia 79
IQ - Iraq 72
EC - Ecuador 66
JP - Giappone 53
ES - Italia 52
AT - Austria 51
PH - Filippine 51
ID - Indonesia 50
PK - Pakistan 50
BE - Belgio 43
PL - Polonia 43
VE - Venezuela 41
UZ - Uzbekistan 37
TH - Thailandia 32
MA - Marocco 31
TW - Taiwan 31
CZ - Repubblica Ceca 29
EU - Europa 26
IR - Iran 24
HN - Honduras 23
AU - Australia 22
CL - Cile 22
PY - Paraguay 22
MY - Malesia 21
JO - Giordania 20
UY - Uruguay 19
PE - Perù 17
AE - Emirati Arabi Uniti 16
KE - Kenya 16
DZ - Algeria 15
LT - Lituania 15
PT - Portogallo 15
EG - Egitto 14
JM - Giamaica 14
CR - Costa Rica 13
IL - Israele 13
SA - Arabia Saudita 13
AL - Albania 12
AZ - Azerbaigian 12
KZ - Kazakistan 12
NI - Nicaragua 12
ET - Etiopia 11
RO - Romania 11
RS - Serbia 11
TN - Tunisia 11
DK - Danimarca 10
EE - Estonia 10
BY - Bielorussia 8
SN - Senegal 8
HR - Croazia 7
BG - Bulgaria 6
BO - Bolivia 6
CI - Costa d'Avorio 6
GR - Grecia 6
GT - Guatemala 6
LB - Libano 6
PA - Panama 6
YE - Yemen 6
BH - Bahrain 5
BS - Bahamas 5
DO - Repubblica Dominicana 5
GA - Gabon 5
NP - Nepal 5
NZ - Nuova Zelanda 5
CH - Svizzera 4
MD - Moldavia 4
NO - Norvegia 4
PR - Porto Rico 4
PS - Palestinian Territory 4
QA - Qatar 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
BB - Barbados 3
CG - Congo 3
HU - Ungheria 3
Totale 37.933
Città #
Singapore 2.093
Ashburn 1.651
Dublin 1.440
San Jose 1.401
Chandler 1.342
Beijing 1.045
Santa Clara 1.036
Jacksonville 1.005
Hong Kong 820
Dearborn 540
Ho Chi Minh City 528
Council Bluffs 522
Nanjing 474
Dallas 438
Boardman 425
Hanoi 415
Izmir 398
Johannesburg 375
Princeton 314
Lauterbourg 271
Los Angeles 268
Ann Arbor 252
San Mateo 239
Parma 210
Wilmington 203
Hefei 200
Shanghai 188
Shenyang 175
New York 158
Helsinki 155
Kunming 147
Toronto 143
Nanchang 140
Munich 135
Jinan 132
São Paulo 123
Hebei 119
Moscow 105
Buffalo 98
Seoul 85
Jiaxing 84
Columbus 82
Tianjin 80
Bremen 79
Seattle 75
Woodbridge 75
Guangzhou 74
Changsha 73
Milan 73
Da Nang 72
The Dalles 71
Grafing 70
Haiphong 70
Marseille 64
Des Moines 63
Brooklyn 53
Houston 49
Zhengzhou 49
Atlanta 47
Rome 47
Turku 43
Kocaeli 41
Brussels 39
London 38
North Bergen 38
Vienna 38
Phoenix 37
Rio de Janeiro 37
Norwalk 36
Orem 35
Brasília 34
Montreal 33
Stockholm 32
Bologna 31
Warsaw 31
Chennai 30
Chicago 30
San Francisco 30
Tashkent 29
Tokyo 29
Belo Horizonte 28
Pune 28
Frankfurt am Main 27
Hải Dương 27
Ningbo 27
Can Tho 26
Fremont 26
Hangzhou 26
Brno 25
Denver 25
Philadelphia 25
Jakarta 24
Baghdad 23
Curitiba 23
Chengdu 22
Manchester 21
Amsterdam 20
Haikou 20
Mexico City 20
Ottawa 20
Totale 22.332
Nome #
Chimeral agglomerates of microparticles for the administration of caffeine nasal powders 408
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 262
A process and an apparatus for administering a predefined amount of a compound 252
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease 236
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 219
Agglomerated Oral Dosage Forms of Artemisinin/β-cyclodextrin Spray-dried Primary Microparticles Showing Increased Dissolution Rate and Bioavailability 217
Agglomerates Containing Pantoprazole Microparticles: Modulating the Drug Release 211
Mechanisms of formation and disintegration of alginate beads obtained by prilling 201
Analysis of the swelling and release mechanisms from drug delivery systems with emphasis on drug solubility and water transport 193
CHIMERAL AGGLOMERATES OF MICRONIZED POWDER FOR NASAL ADMINISTRATION OF ANALGESIC DRUG 186
Alginate containing formulations: are they all the same? 185
Solid-state characterization of tobramycin powders for inhalation 182
Agglomerates of Morphine Microcrystals for Nasal or Buccal Administration 182
A NEW GASTRORETENTIVE DOSAGE FORM: FLOATING DOME MATRIX®. FORMULATION AND IN VITRO RELEASE STUDIES OF RIBOFLAVIN. 180
MULTILAYERED PHARMACEUTICAL FORMULATION 179
Accessorized DPI: a Shortcut towards Flexibility and Patient Adaptability in Dry Powder Inhalation 179
Bioadhesive film for dermal and transdermal drug delivery” 177
Artesunate-clindamycin multi-kinetics and site-specific oral delivery system for antimalaric combination products 176
GASTRO-RESISTANT DELAYED RELEASE PHARMACEUTICAL FORM 175
Assemblage of novel release modules for the development of adaptable drug delivery systems 175
A new assembled delivery system of Clarithromycin and Amoxicillin for Helicobacter Pylori therapy 175
Application of quasi-elastic neutron scattering to the investigation of the dynamics and release properties of single-layer transdermal films containing lidocaine 175
PROGESTERONE LOADED LECITHIN/CHITOSAN NANOPARTICLES FOR TRANSMUCOSAL DELIVERY 175
Analysis of the swelling and release mechanisms from drug delivery systems with emphasis on drug solubility and water transport 175
Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways 171
Cell culture studies of polysaccharide films loaded with cisplatin for the loco-regional therapy of malignant pleural mesothelioma 170
The effect of residual water on antacid activity of sucralfate gel dried by microwaves 168
Clyndamicin-Artesunate Combined Multi-Kinetics Drug Delivery System for Malaria Theraphy 168
Assemblage of drug release modules: Effect of module shape and position in the assembled systems on floating behavior and release rate 168
Dynamics of lipid–saccharide nanoparticles by quasielastic neutron scattering 167
Bioadhesive transdermal film containing caffeine 166
Progesterone loading in lecithin/chitosan nanoparticles for transmucosal delivery 166
BIOAVAILABILITY OF ARTEMISININ-β-CYCLODEXTRIN COMPLEX FORMULATED AS SOFT AGGLOMERATES 166
Effect of residual water content on the physico-chemical properties of sucralfate dried gel obtained by microwave drying 165
Validation of a clean-in-place system on a capsule filling machine 165
Chimerical agglomerates of lecithin/chitosan nanoparticles for powder nasal delivery 165
Assembled delivery modules for clarithromycin release in Helicobacter Pylori therapy 164
Dose administration manoeuvres and patient care in tobramycin dry powder inhalation therapy 164
"Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs 162
Nuove composizioni antivirali e loro utilizzo in terapia e nel trattamento di infezioni virali 161
A drug powder for inhalation administration and a process thereof 160
Structure of Self-Organized Multilayer Nanoparticles for Drug Delivery 159
A Clinical Study of a Methacholine Dry Powder for the Bronchial Challenge Test 159
High shear mixing of lactose and salmeterol xinafoate dry powder blends: biopharmaceutic and aerodynamic performances 158
Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers 158
Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure 157
A novel spray dried formulation for pulmonary administration of insulin 157
A DRUG POWDER FOR INHALATION ADMINISTRATION AND PROCESS THEREOF 156
Chlorhexidine Salt-Loaded Polyurethane Orthodontic Chains: In Vitro Release and Antibacterial Activity Studies 156
A rheometric method for assessing the sucralfate mucin interaction 155
INTRAPLEURAL POLYMERIC FILMS CONTAINING CISPLATIN FOR MALIGNANT PLEURAL MESOTHELIOMA: PRELIMINARY PHARMACOKINETIC DATA IN AN OVINE MODEL 154
Effect of Drying Methods on Retention of Moist Sucralfate Gel Properties 153
Flexibility and drug release features of lipid/saccharide nanoparticles 153
Pulmonary Spray Dried Powders of Tobramycin Containing Sodium Stearate to Improve Aerosolization Efficiency 152
Assembled modules technology for site-specific prolonged delivery of norfloxacin 152
Film for active ingredients dermal and transdermal administration 152
Therapeutic Paint of Cidofovir/Sucralfate Gel Combination Topically Administered by Spraying for treatment of Orf Virus Infections 152
Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats 152
Microparticles comprising a salt of 8-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone having improved adhesion properties for dry powder inhalation 151
Characterization of the permselective properties of rabbit skin during transdermal iontophoresis 150
Dome Matrix® technology : effect of drug solubility on release kinetics of swellable delivery modules 150
The Surface Roughness of Lactose Particles Can Be Modulated by Wet- Smoothing Using a High-Shear Mixer 149
Preparation of poly(methacrylic acid-g-poly(ethylene glycol) nanospheres from methacrylic monomers for pharmaceutical applications 149
Crystalline Microparticles of a Beta-Agonist Coated with a Fatty Acid 148
Disintegration Propensity of Tablets evaluated by Means of Disintegration Force Kinetics 148
A physical analysis of the phenomenon of tablet disintegration 148
Les formes pharmaceutiques du futur 147
Lecithin-chitosan nanoparticles for transmucosal delivery of progesterone via chimerical agglomerates 145
Effect of drying methods on retention of moist sucralfate gel properties 143
Dried sucralfate gel retaining the colloidal properties of sucralfate moist gel 142
Assembled delivery system for the release of two pulses of esomeprazole in combination with sucralfate 142
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 142
INSULIN HIGHLY RESPIRABLE MICROPARTICLES 142
Spray dried amikacin powder for inhalation in cystic fibrosis patients: A quality by design approach for product construction 142
New modules, new assembly kits and new assembles for controlled release of substances 141
Primary microparticles and agglomerates of morphine for nasal insufflation 141
In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays 141
Hyaluronate nanoparticles included in polymer films for the prolonged release of vitamin E for the management of skin wounds 141
Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: Serum and brain levels in rats after nasal insufflation 141
Development and validation of a DESI-HRMS/MS method for the fast profiling of esomeprazole and its metabolites in rat plasma: a pharmacokinetic study. 140
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances 139
Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate 139
Modular systems fitted together for the controlled release of substances 138
Complex product composition generates risks for generic substitution also with dosage forms for intravenous administration 138
Effect of electroosmotic flow on permeation and skin accumulation of acyclovir during transdermal iontophoresis 136
Assay of acyclovir in human skin layers by high-performance liquid chromatography 136
New transdermal bioadhesive film containing oxybutynin: In vitro permeation across rabbit ear skin 135
The use of multilayer poly(vinyl alcohol) adsorption to fabricate drug rich inhalable microparticles. 135
Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 135
Post-iontophoresis transport of ibuprofen lysine across rabbit ear skin 134
Tapioca starch graft copolymers and Dome Matrix® modules assembling technology. I. Effect of module shape on drug release 134
FLOTATION OF DOSAGE FORMS AND DEVICES FOR SITE SPECIFIC THERAPY 134
Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect 134
Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction 133
Respirable amikacin dry powders for inhalation by a Quality bu Design procedure 132
Swelling and drug release in hydrogel matrices: Polymer viscosity and matrix porosity effects 132
Distribution of khellin in excised human skin following iontophoresis and passive dermal transport 132
Comparison of breaking tests for the characterization of the interfacial strength of bilayer tablets 132
COMPOSITION IN POWDER FORM MADE OF SOFT AGGLOMERATES OF A MICRONIZED DRUG AND TWO-COMPONENTS EXCIPIENTS, AND PROCESS FOR THEIR PREPARATION 131
Compositions in powder from made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 131
Totale 16.199
Categoria #
all - tutte 137.001
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.001


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.376 0 0 0 62 51 83 154 226 63 95 141 501
2022/20235.025 627 543 297 320 415 575 81 269 1.748 26 98 26
2023/20241.865 81 215 63 88 153 404 151 133 47 135 157 238
2024/20256.028 116 372 438 360 627 668 144 183 795 593 475 1.257
2025/202612.553 1.139 1.213 1.484 1.135 1.857 740 1.506 399 1.603 889 375 213
2026/20272.648 526 665 699 758 0 0 0 0 0 0 0 0
Totale 38.198